10.1042/CS20040302 91
Journal International de Vitaminologie et de Nutrition, 79(3), 131141
Other highlights from the report include: Increased utilization (+7.9%) and new drug introductions (+2.5%) were the primary drivers of higher spending in 2024, while drug prices remained essentially flat (-0.2%)
All three studies assess several organ-specific outcome measures in animal and in vitro models and reported no acute toxicity across several organ systems. Awesome
Although GLP-1RAs can reduce body weight by 15%25% in controlled settings, real-world adherence is limited, and nearly 70% of patients experience weight regain after discontinuation, raising the risk of long-term pharmacological dependence ( Looking ahead, the future of GLP-1based therapy will depend on addressing safety concerns, improving long-term adherence, and expanding clinical indications
Intermittent fasting is often promoted as a method for losing weight and improving metabolic health